Operating
Change in AR
Vertex Pharmaceuticals Change in AR decreased by 140.0% to -$39.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 123.5%, from $169.60M to -$39.80M. Over 2 years (FY 2022 to FY 2025), Change in AR shows relatively stable performance with a -3.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryLiquidity
SignalLower is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
How to read this metric
A decrease is generally positive as it indicates faster collection of cash from customers.
Detailed definition
This measures the change in the amount of money owed to the company by customers for goods or services delivered on cred...
Peer comparison
Standard metric for all companies; peers in medical devices monitor this closely to manage working capital cycles.
Metric ID:
change_in_accounts_receivableHistorical Data
17 periods
| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $185.30M | $43.50M | $165.20M | $84.10M | $119.50M | $0.00 | $90.50M | $2.90M | $6.10M | $21.03M | $251.60M | $51.80M | $169.60M | $18.40M | $59.90M | $99.40M | -$39.80M |
| QoQ Change | — | -76.5% | +279.8% | -49.1% | +42.1% | -100.0% | — | -96.8% | +110.3% | +244.7% | >999% | -79.4% | +227.4% | -89.2% | +225.5% | +65.9% | -140.0% |
| YoY Change | — | — | — | — | -35.5% | -100.0% | -45.2% | -96.6% | -94.9% | — | +178.0% | +749.2% | -32.6% | — | +15.6% | — | -123.5% |
Range-$39.80M – $251.60M
CAGR-31.9%
Avg YoY Growth+41.5%
Median YoY Growth-40.4%
Change in AR at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's change in ar?
- Vertex Pharmaceuticals (VRTX) reported change in ar of -$39.80M in Q1 2026.
- How has Vertex Pharmaceuticals's change in ar changed year-over-year?
- Vertex Pharmaceuticals's change in ar decreased by 123.5% year-over-year, from $169.60M to -$39.80M.
- What is the long-term trend for Vertex Pharmaceuticals's change in ar?
- Over 2 years (2022 to 2025), Vertex Pharmaceuticals's change in ar has grown at a -3.0% compound annual growth rate (CAGR), from $368.80M to $347.30M.
- What does change in ar mean?
- The change in money owed to the company by customers for past sales.